1.Observations on the Efficacy of Jin’s Three-needle Acupuncture plus Intelligence Training in Treating Mental Retardation in Children
Yijia HU ; Renxiu HUANG ; Zhonghua QIN ; Lijin TAN ; Xuemei LUO ; Yiyi ZENG
Shanghai Journal of Acupuncture and Moxibustion 2015;(3):208-210
Objective To investigate the clinical efficacy of Jin’s three-needle acupuncture plus intelligence training in treating mental retardation in children under 6 years old. Methods Three hundred mental retardation patients aged 0 to 6 were randomly allocated, according to their parents’ willingness, to treatment and control groups, 150 cases each. The treatment group received Jin’s three-needle acupuncture plus intelligence training and the control group, intelligence training alone. An assessment was made using Chinese revised version of the Gesell Developmental Schedules in both groups before and after treatment.Results The total efficacy rate was 84.7% in the treatment group and 73.3% in the control group; there was a statistically significant difference between the two groups (P<0.05). The total efficacy rates in liver-kidney deficiency, heart-spleen deficiency, phlegm and blood stasis, and qi deficiency and blood stasis types were 86.8%, 86.8%, 76.5% and 75.0%, respectively, in the treatment group and 76.2%, 76.8%, 62.5% and 60.0%, respectively, in the control group. There were statistically significant differences in the total efficacy rates in different syndrome types between the two groups (P<0.05). The total efficacy rates in the patients with mild, moderate, severe and very severe diseases were 96.9%, 94.7%, 66.7% and 44.4%, respectively, in the treatment group and 90.0%, 82.5%, 47.8% and 35.3%, respectively, in the control group. There was a statistically significant difference in the total efficacy rate between the two groups of patients with moderate, severe or very severe disease (P<0.05).Conclusion Jin’s three-needle acupuncture plus intelligence training is an effective way to treat mental retardation in children.
2.Community promotion of superficial needling plus club swing for post-stroke motion impairment of the shoulder joint
Huanhuan NI ; Yaochi WU ; Xiangdong SHI ; Yang LI ; Yiyi ZHANG ; Huiling ZENG ; Li JI ; Dequan HUANG ; Chunshui HUANG ; Chouping HAN
Journal of Acupuncture and Tuina Science 2017;15(2):109-114
Objective: To investigate the community promotion feasibility of superficial needling plus club swing for post-stroke motion impairment of the shoulder joint. Methods:A total of 180 cases (duration <1.5 years) with post-stroke motion impairment of the shoulder joint were recruited from three community health centers in Changning District, 60 from each community. They were randomly allocated into an observation group (n=90) and a control group (n=90). Patients in both groups received standard internal and rehabilitation care. Patients in the observation group received additional superficial needling plus club swing. The visual analogue scale (VAS) was conducted before and 60 d after the treatment to evaluate the severity of shoulder pain. The active movement of the shoulder joint and activities of daily living (ADL) were also observed. Results:There were no between-group statistical differences before the treatment (allP>0.05). After a 60-day treatment, the shoulder pain severity, active range of motion of the shoulder joint and ADL in the observation group were significantly improved than those in the control group (allP<0.01). In addition, no adverse events were reported by participants in the observation group. Conclusion:Superficial needling plus club swing plays a positive role in improving post-stroke motion impairment of the shoulder joint. This safe, reliable and economical therapy has good patient compliance and is suitable for community promotion.
3.Paclitaxel-eluting balloon versus drug-eluting stent for in-stent restenosis: comparative study of curative effect
Shuyi ZENG ; Zhengdong WANG ; Jian CHEN ; Ping LI ; Wenchao XIE ; Zhihai LIN ; Yiyi LI
Journal of Interventional Radiology 2017;26(9):839-842
Objective To compare the safety and effectiveness of drug-eluting balloon (DEB) with paclitaxel and drug eluting stent (DES) in treating in-stent restenosis (ISR).Methods The clinical data of a total of 76 patients with ISR,who were admitted to authors' hospital to receive stem implantation during the period from January 2012 to September 2014,were retrospectively analyzed.According to the therapeutic means,the patients were divided into paclitaxel DEB group (n=32) and paclitaxel DES group (n=44).The general clinical information and coronary artery angiography findings were collected.The patients were followed up for one year;the all-cause mortality,cardiac death,myocardial infarction,in-stent thrombosis,target lesion revascularization,target vessel revascularization,and major adverse cardiac events were documented.Results No obvious difference in the general data of patients existed between group DEB and group DES (P>0.05).The incidences of left anterior descending artery ISR in DEB group and in DES group were 43.75% and 47.73% respectively.The ISR target vessel types of the two groups were quite similar (P>0.05).No statistically significant differences in ISR type,ISR lesion type and characteristics of in-stent restenosis existed between the two groups (P>0.05).One-year following-up examinations indicated that no statistically significant differences in all-cause mortality,cardiac death,myocardial infarction,in-stent thrombosis,target lesion revascularization,target vessel revascularization,and major adverse cardiac events existed between the two groups (P>0.05).Further analysis revealed that no significant difference in event-free survival existed between the two groups (P>0.05).Conclusion For the treatment of ISR,the use of paclitaxel DEB is safe and feasible,its curative effect is not less than DES.
4.Effects of Honokiol on cognitive function in mice with kainic acid-induced epilepsy.
Qingmei WANG ; Min SHU ; Qianzi XU ; Yiyi XIE ; Shengzhe RUAN ; Jianda WANG ; Linghui ZENG
Journal of Zhejiang University. Medical sciences 2018;47(5):450-456
OBJECTIVE:
To investigate the effects of Honokiol on cognitive function in mice with epilepsy.
METHODS:
Kainic acid (38 mg/kg) was intraperitoneally injected in 5 weeks old male ICR mice to induce epilepsy. Honokiol at dose of 3, 10, 30 mg/kg was given to epilepic mice by intraperitoneal injection for 10 days. Fluoro-Jade B staining was used to assess neuronal death; Morris water maze and Y maze tests were used to measure cognitive function such as learning and memory; Western blot was performed to detect the expression of acetylated superoxide dismutase (SOD), microtubule associated protein 1 light chain 3-Ⅱ (LC3-Ⅱ) and P62 in hippocampus tissue; thiobarbituric acid and WST-1 methods were used to detect malondialdehyde (MDA) and SOD.
RESULTS:
Compared with control group, the levels of acetylated-SOD, MDA, LC3-Ⅱ, P62 and neuronal death increased, cognitive function and SOD decreased in model group (<0.05 or <0.01). Honokiol at the dose of 10 mg/kg and 30 mg/kg decreased SOD acetylation, MDA content, expression of LC3-Ⅱ and P62, as well as neuronal death, and the cognitive function was improved (<0.05 or <0.01), especially in 30 mg/kg Honokiol group.
CONCLUSIONS
Honokiol alleviates oxidative stress and autophagy degradation disorder, decreases neuronal death, and therefore improves cognitive function in epilepsy mice.
Animals
;
Biphenyl Compounds
;
pharmacology
;
Cognition
;
drug effects
;
Epilepsy
;
chemically induced
;
Gene Expression Regulation
;
drug effects
;
Hippocampus
;
drug effects
;
Kainic Acid
;
Lignans
;
pharmacology
;
Male
;
Malondialdehyde
;
Maze Learning
;
drug effects
;
Mice
;
Mice, Inbred ICR
;
Neurons
;
drug effects
;
Superoxide Dismutase
;
genetics